Tuberous sclerosis complex: review based on new diagnostic criteria
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tuberous sclerosis complex: review based on new diagnostic criteria
Authors
Keywords
-
Journal
ANAIS BRASILEIROS DE DERMATOLOGIA
Volume 93, Issue 3, Pages 323-331
Publisher
FapUNIFESP (SciELO)
Online
2018-06-28
DOI
10.1590/abd1806-4841.20186972
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients
- (2017) John C. Kingswood et al. Orphanet Journal of Rare Diseases
- Natural History of Renal Angiomyolipoma (AML): Most Patients with Large AMLs >4 cm Can Be Offered Active Surveillance as an Initial Management Strategy
- (2016) Jaimin R. Bhatt et al. EUROPEAN UROLOGY
- Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches
- (2016) Katarzyna Switon et al. IUBMB LIFE
- New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex
- (2016) Hilaire C Lam et al. JOURNAL OF PATHOLOGY
- Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
- (2016) Jacqueline A French et al. LANCET
- Everolimus for subependymal giant cell astrocytoma: 5-year final analysis
- (2015) David N. Franz et al. ANNALS OF NEUROLOGY
- Composite renal cell carcinoma and angiomyolipoma in a patient with Tuberous sclerosis: A diagnostic dilemma
- (2015) Aanchal Kakkar et al. CUAJ-Canadian Urological Association Journal
- Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review
- (2015) K. Sadowski et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Neurological and neuropsychiatric aspects of tuberous sclerosis complex
- (2015) Paolo Curatolo et al. LANCET NEUROLOGY
- Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
- (2015) Jeffrey P. MacKeigan et al. NEURO-ONCOLOGY
- Tuberous Sclerosis Complex
- (2015) Francis J. DiMario et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Tuberous Sclerosis Complex: An Update for Dermatologists
- (2015) Stephanie K. Jacks et al. PEDIATRIC DERMATOLOGY
- Annual review of children with tuberous sclerosis
- (2014) K H Ng et al. Archives of Disease in Childhood-Education and Practice Edition
- Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in Tuberous Sclerosis Complex
- (2014) R. Balestri et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- TOSCA – first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex
- (2014) John C Kingswood et al. Orphanet Journal of Rare Diseases
- Cardiovascular Manifestations of Tuberous Sclerosis Complex and Summary of the Revised Diagnostic Criteria and Surveillance and Management Recommendations From the International Tuberous Sclerosis Consensus Group
- (2014) Robert B. Hinton et al. Journal of the American Heart Association
- Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex
- (2013) Katarzyna Kotulska et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- A Novel Topical Rapamycin Cream for the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex
- (2013) James W. Wheless et al. JOURNAL OF CHILD NEUROLOGY
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Hope Northrup et al. PEDIATRIC NEUROLOGY
- Possible Prevention of Tuberous Sclerosis Complex Lesions
- (2013) K. Kotulska et al. PEDIATRICS
- Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex
- (2013) Mary Kay Koenig et al. Drugs in research & development
- Tuberous sclerosis complex
- (2012) Daniela Araujo Rodrigues et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil
- (2012) Magda Blessmann Weber et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
- (2011) D. M. Davies et al. CLINICAL CANCER RESEARCH
- Topical Rapamycin
- (2010) Anna K. Haemel et al. ARCHIVES OF DERMATOLOGY
- New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis
- (2010) Elliot T. Weiss et al. LASERS IN SURGERY AND MEDICINE
- Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas
- (2008) S. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started